CarlRogastonWillisMD

PubMed

• 9 citations
  Application of a Drug-Induced Apoptosis Assay to Identify Treatment Strategies in Recurrent or Metastatic Breast Cancer
  Linda D. Bosserman, Karl Rogers, Carl Rogaston Willis, Dirk C. Davidson, Pat Whitworth, Misagh Karimi, G. Upadhyaya, James Rutledge, Allan Hallquist, Mathieu Perree, C...> ;Plos One. 2015 May 29
• 8 citations
  A phase I/II study examining pentostatin, chlorambucil, and theophylline in patients with relapsed chronic lymphocytic leukemia and non-Hodgkin’s lymphoma
  Carl R. Willis, Amy Goodrich, Kathy Park, Jamie K. Waselenko, Margaret S. Lucas, Amy Reese, Louis F. Diehl, Michael R. Grever, John C. Byrd, Ian W. Flinn> ;Annals of Hematology. 2006 Mar 4
• 7 citations
  Carboxyamido-triazole (CAI)--a novel "static" signal transduction inhibitor induces apoptosis in human B-cell chronic lymphocytic leukemia cells.
  Jamie K. Waselenko, Charlotte Shinn, Carl R. Willis, Ian W. Flinn, Michael R. Grever, John C. Byrd> ;Leukemia & Lymphoma. 2001 Sep 1
• 23 citations
  UCN-01 induces cytotoxicity toward human CLL cells through a p53-independent mechanism.
  John C. Byrd, Charlotte Shinn, Carl R. Willis, Ian W. Flinn, Theresa Lehman, Edward A. Sausville, David M. Lucas, Michael R. Grever> ;Experimental Hematology. 2001 Jun 1
• 16 citations
  A dose-finding study of liposomal daunorubicin with CVP (COP-X) in advanced NHL
  Ian W. Flinn, Steven N. Goodman, L. Post, J. Jamison, Carole B. Miller, S D Gore, Louis F. Diehl, Carl R. Willis, Richard F. Ambinder, John C. Byrd> ;Annals of Oncology. 2000 Jun 1
• 127 citations
  Depsipeptide (FR901228): A novel therapeutic agent with selective, in vitro activity against human B-cell chronic lymphocytic leukemia cells
  John C. Byrd, Charlotte Shinn, Rajani Ravi, Carl R. Willis, Jamie K. Waselenko, Ian W. Flinn, Nancy A. Dawson, M. R. Grever> ;Blood. 1999 Aug 15
• Join now to see all